Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
NCT Number: NCT06415630
Reintubation is an adverse postoperative complication in patients with Type A aortic dissection (AAD) that correlates to poor outcomes. This study aims to analyze the risk factors associated with reintubation and to create a fully automated score model to predict the incidence of reintubation. A total of 861 patients diagnosed with AAD and undergoing surgical procedures in a single institution between January 2018 and October 2023 were selected in wuhan Union Hospital. Preoperative and postoperative informmation was used for seeking risk factors and build prediction model for postoperative reintubation. Finally, 5 risk factors wasidentified and a nomogram was established for predicting postoperative reintubation in patients with AAD.
Looking for future studies?
Notify Me19 year–90 year
All sexes
Observational
Wuhan, Hubei, 430022, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(1) patients diagnosed with AAD admitted for open surgery; (2) aged 18 years or older.
Exclusion criteria
(1) patients deceased during or within 24 hours after surgery; (2) patients with preoperative intubation.
Patients with type A aortic dissection undergone surgery.
Time frame: 3 month
reintubation incidence in patients with type A aortic dissection undergoing surgery
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Other
Multiple Automated Machine-learning Prediction Models for Postoperative Reintubation in Patients With Acute Aortic Dissection
Acronym: ADreintubate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07332923
Adenocarcinoma, Carcinoma
Fuzhou, Fujian, China
View Trial DetailsNCT04711889
Acute Aortic Syndrome, Aortic Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04831073
Acute Aortic Syndrome, Aneurysm
Bruges, Belgium
View Trial DetailsNCT05751200
Type A Aortic Dissection
Xi'an, Shaanxi, China
View Trial Details